232 related articles for article (PubMed ID: 31158785)
1. One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry.
Billette de Villemeur E; Versaevel B
J Health Econ; 2019 May; 65():260-283. PubMed ID: 31158785
[TBL] [Abstract][Full Text] [Related]
2. Outsourcing chemical synthesis in the drug discovery process.
Festel G
Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
[TBL] [Abstract][Full Text] [Related]
3. Biopharma CRO industry in China: landscape and opportunities.
Xia C; Gautam A
Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
[TBL] [Abstract][Full Text] [Related]
4. Strategic groups in the biopharmaceutical industry: implications for performance.
Erden Z; von Krogh G; Nytorp C; Hultberg M
Drug Discov Today; 2009 Aug; 14(15-16):726-30. PubMed ID: 19416760
[TBL] [Abstract][Full Text] [Related]
5. Bioanalytical outsourcing: transitioning from Pharma to CRO.
Hayes R
Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
[No Abstract] [Full Text] [Related]
6. Financial risk of the biotech industry versus the pharmaceutical industry.
Golec J; Vernon JA
Appl Health Econ Health Policy; 2009; 7(3):155-65. PubMed ID: 19799470
[TBL] [Abstract][Full Text] [Related]
7. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments.
Han E; Kim TH; Jeung MJ; Lee EK
Clin Ther; 2013 Jul; 35(7):941-9. PubMed ID: 23806327
[TBL] [Abstract][Full Text] [Related]
8. Bioanalytical outsourcing models in pharmaceutical companies.
Zimmer D
Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
[No Abstract] [Full Text] [Related]
9. Outsourcing lead optimization: the eye of the storm.
Clark DE
Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
[TBL] [Abstract][Full Text] [Related]
10. Create a translational medicine knowledge repository--research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?
Littman BH; Marincola FM
J Transl Med; 2011 May; 9():56. PubMed ID: 21569250
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation and cost-effectiveness thresholds: signals to firms and implications for R & D investment and innovation.
Vernon JA; Goldberg R; Golec J
Pharmacoeconomics; 2009; 27(10):797-806. PubMed ID: 19803536
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?
Billette de Villemeur E; Scannell JW; Versaevel B
Drug Discov Today; 2022 Nov; 27(11):103333. PubMed ID: 36007753
[TBL] [Abstract][Full Text] [Related]
13. Outsourcing discovery.
Mallapaty S
Nature; 2017 Dec; 552(7683):S5. PubMed ID: 29219992
[No Abstract] [Full Text] [Related]
14. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
Dierks RML; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
[TBL] [Abstract][Full Text] [Related]
15. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
Abberley L
Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
[No Abstract] [Full Text] [Related]
16. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
[TBL] [Abstract][Full Text] [Related]
17. Should financial incentives be used to differentially reward 'me-too' and innovative drugs?
Pekarsky B
Pharmacoeconomics; 2010; 28(1):1-17. PubMed ID: 20014872
[TBL] [Abstract][Full Text] [Related]
18. Aspects of research and development contract terms in the bio/pharmaceutical sector.
Banerjee T
Adv Health Econ Health Serv Res; 2012; 23():1-33. PubMed ID: 23156659
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical futures: made in China?
Cyranoski D
Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
[No Abstract] [Full Text] [Related]
20. Bioanalytical outsourcing: the two sides of the medal.
Zimmer D
Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
